You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MELT-300

Showing 26 - 50 of 2,336
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Mobility Toolkit: Electronically Augmented Assessment of

Recruiting
  • Gait
  • None- Observational Study
  • Lexington, Kentucky
  • +9 more
Jan 25, 2023

Hypercholesterolemia, Cardiovascular Diseases Trial in Cincinnati (lerodalcibep, evolocumab, alirocumab)

Active, not recruiting
  • Hypercholesterolemia
  • Cardiovascular Diseases
  • lerodalcibep
  • +2 more
  • Cincinnati, Ohio
  • +2 more
Jul 13, 2022

Toxicology Trial in Limoges (Urine sampling)

Not yet recruiting
  • Toxicology
  • Urine sampling
  • Limoges, France
    CHU de Limoges
Sep 19, 2023

Chronic Limb-Threatening Ischemia Trial (MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold, Percutaneous Transluminal

Not yet recruiting
  • Chronic Limb-Threatening Ischemia
  • MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold
  • Percutaneous Transluminal Angioplasty (PTA)
  • (no location specified)
Oct 9, 2023

SentiCor-300 Continuous Noninvasive Blood Pressure

Suspended
  • Blood Pressure
  • SentiCor-300
  • Cleveland, Ohio
    Cleveland Clinic
Feb 1, 2023

Atrial Fibrillation Trial (pulmonary vein isolation)

Not yet recruiting
  • Atrial Fibrillation
  • pulmonary vein isolation
  • (no location specified)
Jan 25, 2023

Mild Cognitive Impairment, Alzheimer, Hyperglycemia Trial (Coenzyme Q10, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • +3 more
  • Coenzyme Q10
  • Placebo
  • (no location specified)
Sep 10, 2023

Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)

Not yet recruiting
  • Polymyalgia Rheumatica
  • Secukinumab 300 mg
  • +2 more
  • (no location specified)
Mar 6, 2023

Critical Illness Trial in Taipei (GRV thresholds)

Not yet recruiting
  • Critical Illness
  • GRV thresholds
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 31, 2023

Chronic Spontaneous Urticaria, Chronic Urticaria, Idiopathic Trial in Copenhagen (omalizumab 300 mg every four weeks, omalizumab

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Chronic Urticaria, Idiopathic
  • omalizumab 300 mg every four weeks
  • omalizumab 300 mg every six weeks
  • Copenhagen, Copenhagen N, Denmark
    Department of Dermatology, Bispebjerg Hospital
Jun 21, 2023

Ovarian Function Insufficiency, Fertility Issues, Infertility,Female Trial in Abu Dhabi (Follitropin beta injection 150 IU,

Not yet recruiting
  • Ovarian Function Insufficiency
  • +3 more
  • Follitropin beta injection 150 IU
  • Follitropin beta injection 300 IU
  • Abu Dhabi, United Arab Emirates
    ART Fertility Clinics LLC
Feb 1, 2023

Alcohol Use Disorder Trial in New Haven (Pregnenolone, Placebo)

Not yet recruiting
  • Alcohol Use Disorder
  • New Haven, Connecticut
  • +1 more
Mar 10, 2023

Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)

Not yet recruiting
  • Sjogrens Syndrome
  • Ianalumab (VAY736)
  • Placebo
  • (no location specified)
Aug 3, 2023

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Polycythemia Vera Trial in Korea, Republic of, Malaysia (PTG-300)

Active, not recruiting
  • Polycythemia Vera
  • Incheon, Korea, Republic of
  • +7 more
Mar 8, 2022

Study of Minirin Melt® in Adult Patients With Nocturia

Terminated
  • Nocturia
  • Daegu, Korea, Republic of
    Daegu Fatima Hospital (there may be other sites in this country)
Feb 2, 2021

Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)

Active, not recruiting
  • Coronavirus Infections
  • tixagevimab/cilgavimab 150+150 mg
  • +2 more
  • Moscow, Russian Federation
    Moscow City Clinical Hospital 52
Aug 7, 2023

Human Immunodeficiency Virus (HIV) Trial (Doravirine, Tenofovir, Lamivudine, ATRIPLA™, Placebo)

Active, not recruiting
Has Results
  • Human Immunodeficiency Virus (HIV)
  • Doravirine, Tenofovir, Lamivudine
  • +2 more
  • (no location specified)
Sep 1, 2022

Healthy Volunteers Trial in San Antonio (Midazolam injection, Ketamine Injectable Product, MELT-100)

Completed
  • Healthy Volunteers
  • Midazolam injection
  • +2 more
  • San Antonio, Texas
    WWCT
Feb 22, 2021

Soil-Transmitted Helminthiasis (STH) Trial in Americaninhas, Accra (ZP5-9676 600 mg dose, Placebo)

Not yet recruiting
  • Soil-Transmitted Helminthiasis (STH)
  • ZP5-9676 600 mg dose
  • Placebo
  • Americaninhas, Brazil
  • +1 more
Nov 14, 2023

Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)

Active, not recruiting
  • Beta Thalassaemia
  • Safety and Efficacy assessments
  • Milan, Italy
    Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022

Hereditary Hemochromatosis Trial in Canada, United States (PTG-300)

Completed
  • Hereditary Hemochromatosis
  • Fayetteville, Georgia
  • +10 more
Mar 1, 2022

Eliminating HCV Infection Among PWUD

Recruiting
  • Hepatitis C, Chronic
  • Drug Use
  • Vancouver, British Columbia, Canada
    Vancouver Infectious Diseases Centre
Jul 22, 2022

Glioblastoma Trial in Canada, China, United States (drug, other, radiation)

Active, not recruiting
  • Glioblastoma
  • Enzastaurin Hydrochloride
  • +3 more
  • Birmingham, Alabama
  • +62 more
Oct 11, 2022

Survey of Human Rabies Immune Globulin Safety in Children

Recruiting
  • Rabies
  • +3 more
  • Human rabies immune globulin 300 IU/mL
  • Houston, Texas
    Houston Methodist
Aug 22, 2022